Labshake search
Citations for R&D Systems :
1951 - 2000 of 4069 citations for 3 Methoxy 2 2 4 4 Tetrabde Unlabeled 50 Ug Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2021Quote: ... 25 ng/mL mouse Wnt3a (R&D Systems).
-
bioRxiv - Microbiology 2021Quote: ... with IFNγ (20 ng / mL, R&D Systems) were supplemented into X-VIVO 15 media and 5% fetal bovine serum at indicated time points prior to lysis.
-
bioRxiv - Cancer Biology 2021Quote: ... and 20 ng/ml OSM (R&D System) for 5 days ...
-
bioRxiv - Microbiology 2020Quote: ... 10 ng/ml TGF-β (R&D systems) and 2.5 ng/ml TNF-α (R&D systems ...
-
bioRxiv - Microbiology 2020Quote: ... 100 ng/mL rIL-1β (R&D Systems), 5 µM caspase inhibitors zVAD-fmk ...
-
bioRxiv - Developmental Biology 2022Quote: ... 100ng/mL NOGGIN (R&D Systems, Cat#6057), 10µM Y-27632 (APExBIO ...
-
bioRxiv - Bioengineering 2022Quote: ... followed by 200ng/mL FGF9 (R&D Systems) and 1µg/mL heparin (Sigma Aldrich ...
-
bioRxiv - Developmental Biology 2022Quote: ... 100ng/mL NOGGIN (R&D Systems, Cat#6057), 10µM Y-27632 (APExBIO ...
-
bioRxiv - Neuroscience 2022Quote: ... and 20 ng/ml EGF (R&D Systems) for 19 days with daily medium change in the first 10 days ...
-
bioRxiv - Immunology 2022Quote: ... 250 U/ml IFN-α (R&D Systems), 20 ng/ml IL-6 (Peprotech ...
-
bioRxiv - Bioengineering 2022Quote: ... and 10 ng/ mL HGF (R&D Systems). On day 8 post induction ...
-
bioRxiv - Cell Biology 2022Quote: ... and FGF2 (12 ng/ml, R&D Systems). For in vitro differentiation of EpiSC-L cells ...
-
bioRxiv - Cell Biology 2022Quote: ... Activin A (20 ng/ml, R&D Systems), and FGF2 (12 ng/ml ...
-
bioRxiv - Biochemistry 2022Quote: ... and 30ng/mL IFN-γ (R&D Systems).
-
bioRxiv - Cancer Biology 2020Quote: ... IFN-λ2 (60 ng/ml, R&D Systems), and custom IFN-λ3 (20 ng/ml ...
-
bioRxiv - Cancer Biology 2020Quote: ... IFN-λ1 (5 ng/ml, R&D Systems), IFN-λ2 (60 ng/ml ...
-
bioRxiv - Neuroscience 2020Quote: ... and 100 ng/mL Noggin (R&D systems), and the medium was replenished every day ...
-
bioRxiv - Cancer Biology 2020Quote: ... 75 ng/ml mouse IFNγ (R&D Systems) plus 5 ng/ml mouse TNFα (PeproTech ...
-
bioRxiv - Biochemistry 2021Quote: ... 1 μg/mL recombinant SHH (R&D Systems), 30 μM 20(S)-hydroxycholesterol (Cayman Chemicals) ...
-
bioRxiv - Neuroscience 2022Quote: ... 100 ng/mL Activin A (R&D systems), and 3 μM of CHIR99021 (Cayman Chemical ...
-
bioRxiv - Immunology 2022Quote: ... 5 ng/ml IL-7 (R&D Systems), 5 ng/ml IL-15 (R&D Systems) ...
-
bioRxiv - Immunology 2022Quote: ... and rmTGFβ (10 ng/ml; R&D Systems) in a 96-well U-bottom plate ...
-
bioRxiv - Immunology 2022Quote: ... and IL- 23 (100ng/ml) (R&D Systems). Cells were expanded for 2 weeks in media replenished for 2DG and IL-2.
-
bioRxiv - Cell Biology 2022Quote: ... or 1 μg/ml FcDR5 (R&D systems) as indicated ...
-
bioRxiv - Pathology 2022Quote: ... 100 ng/mL interferon γ (R&D Systems), or serum depletion for 6 hrs ...
-
bioRxiv - Immunology 2020Quote: ... 1 µg/ml NKp30 (R&D systems, MAB18491) and 1 µg/ml NKp46 (BD Biosciences ...
-
bioRxiv - Molecular Biology 2019Quote: ... TNFα stimulations (10 ng/ml, R&D Systems) or staurosporine (2 or 20 nM ...
-
bioRxiv - Immunology 2019Quote: ... TGF-β (10 ng/ml, R&D systems) and TNF-α (2.5 ng/ml ...
-
bioRxiv - Biochemistry 2019Quote: ... M-CSF (10 ng/ml, R&D Systems), 1% penicillin-streptomycin (Gibco) ...
-
bioRxiv - Immunology 2020Quote: ... and 20ng/ml rmIL-23 (R&D systems); non-pathogenic Th17 ...
-
bioRxiv - Molecular Biology 2020Quote: ... Activin-A (100 ng/ml) (R&D Systems) was treated for 30 min ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... Anti-Pdx1 (1μg/ml) (AF2517, R&D Systems) and Anti-Actin-beta (1:1000 ...
-
bioRxiv - Immunology 2019Quote: ... or ICAM-1(20μg/ml; R&D Systems), or the appropriate isotype control IgG (20 μg/ml ...
-
bioRxiv - Cancer Biology 2019Quote: ... supplemented with 50ng/ml SCF (R&D Systems), 3IU/ml EPO (KIRIN or Peprotech) ...
-
bioRxiv - Molecular Biology 2020Quote: ... 20 ng/mL of bFGF (R&D Systems), and 20 ng/mL of EGF (Sigma-Aldrich ...
-
bioRxiv - Immunology 2021Quote: ... and 20ng/ml GM-CSF (R&D System) at 37°C ...
-
bioRxiv - Neuroscience 2019Quote: ... TrkB-Fc bodies (5mg/mL, R&D Systems) and K252a (200 nM ...
-
bioRxiv - Developmental Biology 2019Quote: ... and rGDNF (R&D Systems, 10 ng/ml) were added for longer cultures ...
-
bioRxiv - Cancer Biology 2019Quote: ... and FGF2 (20 ng/ml, R&D Systems). CD133-negative NSCCs were cultured in DMEM supplemented with 10% FBS and penicillin/streptomycin (50 U/ml).
-
bioRxiv - Immunology 2019Quote: ... and 1000 U/mL IL4 (R&D Systems) for 5 days ...
-
bioRxiv - Cancer Biology 2020Quote: ... TNFα (5 μg/ml, #MAB4101, R&D Systems), or CXCL9 (6 μg/ml ...
-
bioRxiv - Bioengineering 2019Quote: ... 80 ng mL−1 BMP4 (R&D systems), and 80 ng mL−1 VEGF (R&D systems) ...
-
bioRxiv - Genetics 2020Quote: ... or IFN-λ3 (R&D Systems, 100ng/ml) for 24 hrs ...
-
bioRxiv - Immunology 2021Quote: ... 20 ng/mL IL-1β (R&D Systems), 25 ng/mL IL-23 (R&D Systems ...
-
bioRxiv - Immunology 2021Quote: ... 25 ng/mL IL-23 (R&D Systems) for 72 hours.
-
bioRxiv - Immunology 2021Quote: ... 20 ng/mL IL-6 (R&D Systems), and/or 0.1 ng/mL TGF-β (R&D Systems) ...
-
bioRxiv - Genetics 2021Quote: ... 10ng/ml TNFα (210-TA, R&D systems), combination of 500 nM MG132 and 10ng/ml TNFα or with media containing the same volume of DMSO (vehicle control) ...
-
bioRxiv - Cell Biology 2021Quote: Recombinant TGFβ (10 ng/ml, R&D System) was used to induce myofibroblast transformation ...
-
bioRxiv - Developmental Biology 2021Quote: ... and FGF2 (20 ng/mL; R&D Systems), which was added for 24 hours ...
-
bioRxiv - Developmental Biology 2021Quote: ... and FGF2 (20 ng/mL; R&D Systems) for 2 days ...